Home > Boards > US Listed > Biotechs > ImmunoGen, Inc. (IMGN)

I believe the 4 presentation they're making at

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
skitahoe Member Profile
 
Followed By 78
Posts 3,946
Boards Moderated 0
Alias Born 08/14/03
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/25/2020 8:39:43 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/25/2020 8:39:01 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/25/2020 8:38:30 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/25/2020 8:38:05 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/25/2020 8:37:34 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/14/2020 5:20:14 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 4:54:02 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 12:40:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/14/2020 6:38:07 AM
ImmunoGen Reports Recent Progress and 2019 Financial Results Business Wire - 2/14/2020 6:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 2:59:40 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/12/2020 3:04:36 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 7:53:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:28:30 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:28:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:27:09 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:26:34 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:25:29 AM
Schedule 13g Edgar (US Regulatory) - 2/10/2020 9:11:28 AM
ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences Business Wire - 2/6/2020 4:30:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2020 11:50:20 AM
ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 2/3/2020 4:30:00 PM
ImmunoGen Announces Conference Call to Discuss Its 2019 Operating Results Business Wire - 1/30/2020 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/27/2020 4:13:56 PM
ImmunoGen Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Business Wire - 1/27/2020 4:01:00 PM
skitahoe   Friday, 11/01/19 03:08:44 PM
Re: whytestocks post# 635
Post # of 667 
I believe the 4 presentation they're making at ASH on IMGN632 will spur additional interest in the stock, and hopefully we'll end the year much closer to the high, rather than the lows where we're currently languishing.

As someone in remission after stem cells for ALL I'm happy to hear they're now working with it. I don't believe they're going after the specific form I have, but I know that much off label use is made, so no telling if it could be effective. I'm approaching 5 years post stem cells, but remain on chemo as it greatly diminishes the likelihood of coming out of remission. I hope not to ever need anything more, but it would still nice to know it exists if I do.

Gary

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist